Suppression of RIZ in biologically unfavourable neuroblastomas

International Journal of Oncology

Volumn 37, Issue 5, 2010, Pages 1323-1330

  Geli, Janos ^a   Kiss, Nimrod ^a   Kogner, Per ^a   Larsson, Catharina ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

MRNA expression; Neuroblastoma; Promoter methylation; RIZ

Indexed keywords

MESSENGER RNA; PROTEIN; PROTEIN RIZ; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CHROMOSOME 1P; CHROMOSOME DELETION; CLINICAL ARTICLE; DNA METHYLATION; FEMALE; GANGLIONEUROMA; GENE; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NEUROBLASTOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; RIZ1 GENE;

BASE SEQUENCE; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; DNA METHYLATION; DNA-BINDING PROTEINS; FEMALE; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MOLECULAR SEQUENCE DATA; NEOPLASM STAGING; NEUROBLASTOMA; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 77957859032     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000784     Document Type: Article

References (45)

1. Maris JM, Hogarty MD, Bagatell R and Cohn SL: Neuroblastoma. Lancet 369: 2106-2120, 2007.
2. Attiyeh EF, London WB, Mosse YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK and Maris JM: Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med 353: 2243-2253, 2005. (Pubitemid 41697287)
3. Brodeur GM, Green AA, Hayes FA, Williams KJ, Williams DL and Tsiatis AA: Cytogenetic features of human neuroblastomas and cell lines. Cancer Res 41: 4678-4686, 1981. (Pubitemid 12201390)
4. Mosse YP, Laudenslager M, Longo L, Cole KA, Wood A, Attiyeh EF, Laquaglia MJ, Sennett R, Lynch JE, Perri P, Laureys G, Speleman F, Kim C, Hou C, Hakonarson H, Torkamani A, Schork NJ, Brodeur GM, Tonini GP, Rappaport E, Devoto M and Maris JM: Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 455: 930-935, 2008.
5. Bauer A, Savelyeva L, Claas A, Praml C, Berthold F and Schwab M: Smallest region of overlapping deletion in 1p36 in human neuroblastoma: a 1 Mbp cosmid and PAC contig. Genes Chromosomes Cancer 31: 228-239, 2001. (Pubitemid 32521753)
6. Caron H, Spieker N, Godfried M, Veenstra M, van Sluis P, De Kraker J, Voute P and Versteeg R: Chromosome bands 1p35-36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted. Genes Chromosomes Cancer 30: 168-174, 2001. (Pubitemid 32044597)
7. Cheng NC, van Roy N, Chan A, Beitsma M, Westerveld A, Speleman F and Versteeg R: Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification. Oncogene 10: 291-297, 1995.
8. Martinsson T, Sjoberg RM, Hallstensson K, Nordling M, Hedborg F and Kogner P: Delimitation of a critical tumour suppressor region at distal 1p in neuroblastoma tumours. Eur J Cancer 33: 1997-2001, 1997. (Pubitemid 28123442)
9. Schleiermacher G, Peter M, Michon J, Hugot JP, Vielh P, Zucker JM, Magdelenat H, Thomas G and Delattre O: Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chromosomes Cancer 10: 275-281, 1994.
10. Takeda O, Homma C, Maseki N, Sakurai M, Kanda N, Schwab M, Nakamura Y and Kaneko Y: There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chromosomes Cancer 10: 30-39, 1994.
11. White PS, Thompson PM, Gotoh T, Okawa ER, Igarashi J, Kok M, Winter C, Gregory SG, Hogarty MD, Maris JM and Brodeur GM: Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma. Oncogene 24: 2684-2694, 2005.
12. Banelli B, Di Vinci A, Gelvi I, Casciano I, Allemanni G, Bonassi S and Romani M: DNA methylation in neuroblastic tumors. Cancer Lett 228: 37-41, 2005.
13. Cole KA, Attiyeh EF, Mosse YP, Laquaglia MJ, Diskin SJ, Brodeur GM and Maris JM: A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. Mol Cancer Res 6: 735-742, 2008.
14. Schulte JH, Horn S, Schlierf S, Schramm A, Heukamp LC, Christiansen H, Buettner R, Berwanger B and Eggert A: MicroRNAs in the pathogenesis of neuroblastoma. Cancer Lett 274: 10-15, 2009.
15. Huang S: The retinoblastoma protein-interacting zinc finger gene RIZ in 1p36-linked cancers. Front Biosci 4: D528-D532, 1999.
16. Kim KC, Geng L and Huang S: Inactivation of a histone methyltransferase by mutations in human cancers. Cancer Res 63: 7619-7623, 2003. (Pubitemid 37466684)
17. Steele-Perkins G, Fang W, Yang XH, van Gele M, Carling T, Gu J, Buyse IM, Fletcher JA, Liu J, Bronson R, Chadwick RB, De la Chapelle A, Zhang X, Speleman F and Huang S: Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily. Genes Dev 15: 2250-2262, 2001.
18. Abbondanza C, Medici N, Nigro V, Rossi V, Gallo L, Piluso G, Belsito A, Roscigno A, Bontempo P, Puca AA, Molinari AM, Moncharmont B and Puca GA: The retinoblastoma-interacting zinc-finger protein RIZ is a downstream effector of estrogen action. Proc Natl Acad Sci USA 97: 3130-3135, 2000.
19. Canote R, Du Y, Carling T, Tian F, Peng Z and Huang S: The tumor suppressor gene RIZ in cancer gene therapy (review). Oncol Rep 9: 57-60, 2002.
20. Akahira J, Suzuki F, Suzuki T, Miura I, Kamogawa N, Miki Y, Ito K, Yaegashi N and Sasano H: Decreased expression of RIZ1 and its clinicopathological significance in epithelial ovarian carcinoma: correlation with epigenetic inactivation by aberrant DNA methylation. Pathol Int 57: 725-733, 2007.
21. Chadwick RB, Jiang GL, Bennington GA, Yuan B, Johnson CK, Stevens MW, Niemann TH, Peltomaki P, Huang S and De la Chapelle A: Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis. Proc Natl Acad Sci USA 97: 2662-2667, 2000.
22. Geli J, Nord B, Frisk T, Edstrom Elder E, Ekstrom TJ, Carling T, Backdahl M and Larsson C: Deletions and altered expression of the RIZ1 tumour suppressor gene in 1p36 in pheochromocytomas and abdominal paragangliomas. Int J Oncol 26: 1385-1391, 2005.
23. He L, Yu JX, Liu L, Buyse IM, Wang MS, Yang QC, Nakagawara A, Brodeur GM, Shi YE and Huang S: RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis. Cancer Res 58: 4238-4244, 1998.
24. Jiang G, Liu L, Buyse IM, Simon D and Huang S: Decreased RIZ1 expression but not RIZ2 in hepatoma and suppression of hepatoma tumorigenicity by RIZ1. Int J Cancer 83: 541-546, 1999.
25. Sakurada K, Furukawa T, Kato Y, Kayama T, Huang S and Horii A: RIZ, the retinoblastoma protein interacting zinc finger gene, is mutated in genetically unstable cancers of the pancreas, stomach, and colorectum. Genes Chromosomes Cancer 30: 207-211, 2001. (Pubitemid 32044603)
26. Carling T, Du Y, Fang W, Correa P and Huang S: Intragenic allelic loss and promoter hypermethylation of the RIZ1 tumor suppressor gene in parathyroid tumors and pheochromocytomas. Surgery 134: 932-939, 2003.
27. Hasegawa Y, Matsubara A, Teishima J, Seki M, Mita K, Usui T, Oue N and Yasui W: DNA methylation of the RIZ1 gene is associated with nuclear accumulation of p53 in prostate cancer. Cancer Sci 98: 32-36, 2007.
28. Lal G, Padmanabha L, Smith BJ, Nicholson RM, Howe JR, O'Dorisio MS and Domann FE: RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma. Cancer 107: 2752-2759, 2006. (Pubitemid 44937027)
29. Oshimo Y, Oue N, Mitani Y, Nakayama H, Kitadai Y, Yoshida K, Chayama K and Yasui W: Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma. Int J Cancer 110: 212-218, 2004. (Pubitemid 38580393)
30. Piao GH, Piao WH, He Y, Zhang HH, Wang GQ and Piao Z: Hyper-methylation of RIZ1 tumor suppressor gene is involved in the early tumorigenesis of hepatocellular carcinoma. Histol Histopathol 23: 1171-1175, 2008.
31. Buyse IM, Shao G and Huang S: The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein. Proc Natl Acad Sci USA 92: 4467-4471, 1995.
32. Alaminos M, Davalos V, Cheung NK, Gerald WL and Esteller M: Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma. J Natl Cancer Inst 96: 1208-1219, 2004. (Pubitemid 39232712)
33. Hoebeeck J, Michels E, Pattyn F, Combaret V, Vermeulen J, Yigit N, Hoyoux C, Laureys G, De Paepe A, Speleman F and Vandesompele J: Aberrant methylation of candidate tumor suppressor genes in neuroblastoma. Cancer Lett 273: 336-346, 2009.
34. Geli J, Kogner P, Lanner F, Natalishvili N, Juhlin C, Kiss N, Clark GJ, Ekstrom TJ, Farnebo F and Larsson C: Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma. Int J Cancer 123: 389-394, 2008.
35. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M and Hedborg F: Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11: 1466-1477, 1993.
36. Martinsson T, Sjoberg RM, Hedborg F and Kogner P: Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms. Cancer Res 55: 5681-5686, 1995.
37. Sasaki O, Meguro K, Tohmiya Y, Funato T, Shibahara S and Sasaki T: Altered expression of retinoblastoma protein-interacting zinc finger gene, RIZ, in human leukaemia. Br J Haematol 119: 940-948, 2002. (Pubitemid 35463817)
38. Wang Q, Diskin S, Rappaport E, Attiyeh E, Mosse Y, Shue D, Seiser E, Jagannathan J, Shusterman S, Bansal M, Khazi D, Winter C, Okawa E, Grant G, Cnaan A, Zhao H, Cheung NK, Gerald W, London W, Matthay KK, Brodeur GM, and Maris JM: Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. Cancer Res 66: 6050-6062, 2006.
39. Caren H, Ejeskar K, Fransson S, Hesson L, Latif F, Sjoberg RM, Krona C and Martinsson T: A cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylation. Mol Cancer 4: 10, 2005.
40. Caren H, Fransson S, Ejeskar K, Kogner P and Martinsson T: Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours. Br J Cancer 97: 1416-1424, 2007. (Pubitemid 350114785)
41. Fransson S, Martinsson T and Ejeskar K: Neuroblastoma tumors with favorable and unfavorable outcomes: significant differences in mRNA expression of genes mapped at 1p36.2. Genes Chromosomes Cancer 46: 45-52, 2007.
42. Okawa ER, Gotoh T, Manne J, Igarashi J, Fujita T, Silverman KA, Xhao H, Mosse YP, White PS and Brodeur GM: Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas. Oncogene 27: 803-810, 2008.
43. Van Noesel MM, van Bezouw S, Voute PA, Herman JG, Pieters R and Versteeg R: Clustering of hypermethylated genes in neuroblastoma. Genes Chromosomes Cancer 38: 226-233, 2003.
44. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996.
45. Kundu S and Peterson CL: Role of chromatin states in transcriptional memory. Biochim Biophys Acta 1790: 445-455, 2009.